טוען...
RET codon 609 mutations: a contribution for better clinical managing
Medullary thyroid carcinoma currently accounts for 5–8% of all thyroid cancers. The clinical course of this disease varies from extremely indolent tumors that can go unchanged for years to an extremely aggressive variant that is associated with a high mortality rate. As many as 75% of all medullary...
שמור ב:
| Main Authors: | , , , , |
|---|---|
| פורמט: | Artigo |
| שפה: | Inglês |
| יצא לאור: |
Hospital das Clínicas da Faculdade de Medicina da Universidade de São Paulo
2012
|
| נושאים: | |
| גישה מקוונת: | https://ncbi.nlm.nih.gov/pmc/articles/PMC3328822/ https://ncbi.nlm.nih.gov/pubmed/22584703 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.6061/clinics/2012(Sup01)07 |
| תגים: |
הוספת תג
אין תגיות, היה/י הראשונ/ה לתייג את הרשומה!
|